SCHEMBL16367017

SCHEMBL16367017

CCn1c(=O)c2c[nH]nc2n(Cc2ccc(OC)cc2)c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 3/20 0.52
MAPT P10636 2/20 0.49
THRB P10828 1/20 0.49
PDE1B Q01064 4/20 0.48
PDE1A P54750 3/20 0.48
PDE1C Q14123 3/20 0.48
ADORA3 P0DMS8 3/20 0.47
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ADORA1 P30542 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SIRT1 Q96EB6 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
SIRT5 Q9NXA8 1/20 0.45
PDE4A P27815 1/20 0.45
PDE4B Q07343 1/20 0.45
PDE4C Q08493 1/20 0.45
PDE4D Q08499 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7458328 0.88 ALDH1A1 (0.50) MAPTTHRBPDE1BPDE1APDE1C
SCHEMBL8352700 0.77 P2RX4 (0.67) MAPTTHRBKDM4EMEN1KMT2A
SCHEMBL27171716 0.74 PDE1B (0.50) PDE5AMAPTTHRBPDE1BPDE1A
SCHEMBL3665761 0.72 HPGD (0.52) MAPTADORA3KDM4EMEN1KMT2A
SCHEMBL27171798 0.71 PDE1B (0.43) PDE5AMAPTPDE1BPDE1APDE1C
SCHEMBL11193538 0.71 ADORA2A (0.51) ADORA1PDE4APDE4BPDE4CPDE4D
SCHEMBL25241925 0.70 PDE1A (0.54) MAPTPDE1BPDE1APDE1CKDM4E
SCHEMBL2016802 0.70 TNF (0.72) PDE5AMAPTTHRBPDE4BPDE4D
SCHEMBL6266030 0.69 P2RX4 (0.72) MAPTTHRBMEN1KMT2ATDP1
SCHEMBL23679701 0.69 MAPT (0.47) PDE5AMAPTTHRBPDE1BPDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021226407-A1 FREE BASE CRYSTALS INTRA-CELLULAR THERAPIES, INC. (US) 2021-11-11 WO disclosed
EP-3010509-B1 FREE BASE CRYSTALS INTRA CELLULAR THERAPIES INC (US) 2021-07-28 EP disclosed
EP-3733675-A1 SALT CRYSTALS OF A PDE1 INHIBITOR Intra-Cellular Therapies, Inc. (US) 2020-11-04 EP disclosed
EP-3702358-A1 PROCESS FOR PREPARING SALTS OF A KNOWN PDE1 INHIBITOR Intra-Cellular Therapies, Inc. (US) 2020-09-02 EP disclosed
WO-2014205354-A2 FREE BASE CRYSTALS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-12-24 WO disclosed